Click to Visit Our Sustainability Site for More Topic Information Interactive PDF Click on a listing below to be taken directly to that page. Additional information can be found in our Human Rights Policy. Avient received a 75% score on the Human Rights Campaign Foundation’s 2023 Corporate Equality Index.

Sources: 1)    https://verpackungsgesetz-info.de/wp-content/uploads/2021/06/twopager-packaging-amendment-1.pdf 2)    https://ec.europa.eu/commission/presscorner/detail/en/IP_18_3846 3)    https://verpackungsgesetz-info.de/en/#verpackungsgesetz

Avient's Human Rights Policy

Global Compact & fulfilled Communication of Progress (COP) requirements • New Sustainability Strategy overview page including our 2022 AIP ESG metrics • New ESG Performance page with ESG ratings, awards, and certifications • Increased disclosures on carbon emissions, including disclosure of Climate Change Scenario Analysis • Added new Product Stewardship and Chemical Management policies • Enhanced data reporting for Workforce Demographics • Improved social disclosures on human rights, dependent care and special leave and strategic training management 2021 SUSTAINABILITY REPORT Launching integrated sustainability website in parallel with report Aligned with leading reporting frameworks 6 Released July 2022 ESG RATINGS PERFORMANCE ESG AWARDS AND CERTIFICATIONS ESG PERFORMANCE & AWARDS 84th 3 1 2 7 T RAN S FO R MAT IO NAL OVE RV IE W Avient Protective Dyneema ® RECENT TRANSACTIONS Acquired Divested $1.45 B $0.95 B 9 Distribution UPDATED CAPITAL STRUCTURE & LIQUIDITY • Proceeds from completed sale of Distribution used to pay near-term maturing debt to strengthen balance sheet • Fixed/floating debt ratio of ~55/45 • Proven track record of deleveraging following major acquisitions through strong free cash flow generation • 2022 pro forma net debt/adjusted EBITDA expected to be 3.1x $725 $725 $575 $500 $600 $525 $650 $650 $600 Capital Structure Cas h $544 Undr awn Rev olve r $250 Liquidity $3.15B $2.40B 2030 Notes 2029 Term Loan 2026 Term Loan 2025 Notes 2023 Notes After Dyneema Acquisition After Distribution Divestiture $794M (1) $250M reflects estimated undrawn revolver following the divestiture of Distribution 10 PREVIOUS TRANSACTIONS Performance Solutions Products & $0.8 B COLOR $1.4 B Acquired (2020)Divested (2019) 11 • Acquisition of Clariant Color business significantly expanded presence in healthcare, packaging and consumer end markets • Strength of portfolio – double-digit annual EBITDA growth since acquisition • $75 million of realized synergies anticipated in 2022 • Acquisition completed on July 1, 2020 for $1.45 billion. END MARKET FOCUS ON LESS CYCLICAL INDUSTRIES 16 14.8% 17.6% 21.0% 2018 2020 2022 PF 1.8% 2006 15.3% 16.2% 17.0% 2018PF 2020PF 2022E CAI 2.7% 2006 SEM SPECIALTY EBITDA MARGIN EXPANSION 17 • Portfolio transformation accelerates growth in less cyclical, higher margin end markets • Investments in our composites platform continue to drive margin expansion (1) (1) (1) 2018 and 2020 financial information is pro forma to include a full year of Clariant Color acquisition PORTFOLIO EVOLUTION OVER THE YEARS 18 Adj.

Global Compact & fulfilled Communication of Progress (COP) requirements • New Sustainability Strategy overview page including our 2022 AIP ESG metrics • New ESG Performance page with ESG ratings, awards, and certifications • Increased disclosures on carbon emissions, including disclosure of Climate Change Scenario Analysis • Added new Product Stewardship and Chemical Management policies • Enhanced data reporting for Workforce Demographics • Improved social disclosures on human rights, dependent care and special leave and strategic training management 2021 SUSTAINABILITY REPORT Launching integrated sustainability website in parallel with report Aligned with leading reporting frameworks 6 Released July 2022 ESG RATINGS PERFORMANCE ESG AWARDS AND CERTIFICATIONS ESG PERFORMANCE & AWARDS 84th 3 1 2 7 T RAN S FO R MAT IO NAL OVE RV IE W Avient Protective Dyneema ® RECENT TRANSACTIONS Acquired Divested $1.45 B $0.95 B 9 Distribution UPDATED CAPITAL STRUCTURE & LIQUIDITY • Proceeds from completed sale of Distribution used to pay near-term maturing debt to strengthen balance sheet • Fixed/floating debt ratio of ~55/45 • Proven track record of deleveraging following major acquisitions through strong free cash flow generation • 2022 pro forma net debt/adjusted EBITDA expected to be 3.1x $725 $725 $575 $500 $600 $525 $650 $650 $600 Capital Structure Cash $544 Undrawn Revolver $250 Liquidity $3.15B $2.40B 2030 Notes 2029 Term Loan 2026 Term Loan 2025 Notes 2023 Notes After Dyneema Acquisition After Distribution Divestiture $794M (1) $250M reflects estimated undrawn revolver following the divestiture of Distribution 10 PREVIOUS TRANSACTIONS Performance Solutions Products & $0.8 B COLOR $1.4 B Acquired (2020)Divested (2019) 11 • Acquisition of Clariant Color business significantly expanded presence in healthcare, packaging and consumer end markets • Strength of portfolio – double-digit annual EBITDA growth since acquisition • $75 million of realized synergies anticipated in 2022 • Acquisition completed on July 1, 2020 for $1.45 billion. END MARKET FOCUS ON LESS CYCLICAL INDUSTRIES 16 14.8% 17.6% 21.0% 2018 2020 2022 PF 1.8% 2006 15.3% 16.2% 17.0% 2018PF 2020PF 2022E CAI 2.7% 2006 SEM SPECIALTY EBITDA MARGIN EXPANSION 17 • Portfolio transformation accelerates growth in less cyclical, higher margin end markets • Investments in our composites platform continue to drive margin expansion (1) (1) (1) 2018 and 2020 financial information is pro forma to include a full year of Clariant Color acquisition PORTFOLIO EVOLUTION OVER THE YEARS 18 Adj.

Click to Visit Our Sustainability Site for More Topic Information Interactive PDF Click on a listing below to be taken directly to that page. Additional information can be found in our Human Rights Policy. Avient received a 75% score on the Human Rights Campaign Foundation’s 2023 Corporate Equality Index.

Avient includes in its Code of Conduct and Supplier Code of Conduct internal accountability standards related to slavery and human trafficking to which all employees, agents and consultants are required to adhere. Where required by law, we also have specific disclosures and processes in place, including a supplier audit program that focuses on human trafficking. Human Rights Policy

Ergonomics – the science of designing equipment and devices that fit the human body – is increasingly important to the healthcare industry. Food and Drug Administration’s (FDA) draft guidance, “Applying Human Factors and Usability Engineering to Optimize Medical Device Design,” recommends the use of appropriate human factors analysis, testing and validation during the design phase of medical devices to reduce user-related hazards and errors.

Avient's Position on Human Rights- July 2021 View Avient's position on human rights

Avient's Position on Human Rights- July 2021 View Avient's position on human rights